Home About SPA Join SPA Education Newsletter Jobs & Fellowships Volunteer Service Abroad Links of Interest

member button

 

SPA Newsletter

.

Volume 17 Number 3
Summer 2004 Newsletter
spa@societyhq.com

Cholecystectomy in sickle cell anemia patients: Perioperative outcome of 364 cases from the National Preoperative Transfusion Study

Charles M. Haberkern, et al, and the Preoperative Transfusion in Sickle Cell Disease Study Group

The authors of this paper, the sickle Cell Disease study group, reviewed 364 patients with sickle cell disease who underwent cholecystecyomy. There were four groups of patients: Groups 1 and 2 were subjects who were randomized into aggressive (hgb 9-11gm%, hgb S < 30%) or conservative (hgb 9-11gm%) transfusion. Groups 3 and 4 were not randomized for a variety of reasons. Group 3 was not transfused and group 4 was transfused. The patients were sorted into groups as follows: Group 1: 110 patients, Group 2: 120 patients, Group 3: 37 patients, Group 4: 97 patients. Twenty-one percent of the patients were < 10 years of age.

Perioperative care was similar for the patients. All were given general anesthesia and 8% of this group had epidural analgesia as well. The overall complication rate was 39%. Overall morbidity was not affected by preoperative transfusion, but the incidence of morbid events specific to sickle cell disease was highest in patients who were not transfused. Eighteen percent of patients had vaso-occlusive (VOC) episode or acute chest syndrome (ACS). The rate of sickle events (VOC pain, ACS) was significantly higher in group 3, the patients who were not transfused. During the time of the study, laparoscopic procedures became more widely done. In this review the incidence of complications was not different between those who underwent open vs. laparoscopic cholecystecyomy, although hospital stay was shorter in the laparoscopic patients.


Table of Contents


Newsletter Archive

 

 

 

© 2008 Society for Pediatric Anesthesia
2209 Dickens Road, Richmond, VA 23230-2005 • Phone: 804-282-9780 • Fax: 804-282-0090